Company logo
Be a Partner

New Prostate Cancer Treatment 2022- FDA Approved Advanced Prostate Cancer treatment

In 2022, treatment for prostate cancer took a big step forward when the US Food and Drug Administration approved a new treatment. That's the view of many in the medical world right now, who are working tirelessly on new diagnostic techniques, treatments, and even preventative measures for prostate cancer. If we continue at our current pace of advancement, these optimists believe that we can almost eliminate the risk of this common cancer among men. So what will change in 2022? Let's take a look…

  • Cancer

By Priyanka Dutta Deb

2nd Sept'22

Blog Banner Image

Prostate cancer is the second most common type of cancer (after lung cancer) in men worldwide and the second leading cause of cancer death. It is the fourth most commonly diagnosed cancer in the world.  In fact, around one man in every 9 will be diagnosed with prostate cancer by age 85.  According to a study, in 2020, approximately 15 lakh people were diagnosed with prostate cancer worldwide. It is estimated that almost 220,000 new cases of prostate cancer will be diagnosed in the U.S. alone this year. 

There are no reliable early-detection tests for prostate cancer. Current treatment options remain limited due to its ubiquitous location beneath layers of dense tissue and its inability to metastasize outside the prostate gland.


On August 5th, 2022, the FDA approved a new prostate cancer treatment. Meanwhile, FDA has also approved treatments for a few other cancers like refractory multiple myeloma, and many more. The new prostate cancer drug is Darolutamide combined with Docetaxel for treating patients with hormone-sensitive metastatic prostate cancer (HSBC). It may also be combined with docetaxel chemotherapy to treat metastatic castration-sensitive prostate cancer.

Recently, CAR-T therapy has become a revolutionary cancer treatment that harnesses the patient's immune system's power to fight the disease. Oncologists primarily treat patients with certain types of blood cancers, such as leukemia and lymphoma.


This article explains how this generation of treatment will revolutionize prostate cancer treatment in 2022.


The Problem With Prostate Cancer Treatment Today

There are two main types of prostate cancer:

  • Localized prostate cancer (80-90 percent of cases): This type of cancer is confined to the prostate and not spread to any other parts of the body.
  • Advanced prostate cancer (10-20 percent of cases): This type of cancer has spread to other body parts, most commonly to the bones and/or lymph nodes. Advanced prostate cancer is incurable. A man will die of it. The current treatments for prostate cancer are surgery, radiation therapy, and chemotherapy. Surgery involves removing the prostate. Radiation therapy uses high-energy X-ray beams to destroy cancer cells.

These treatments tend to have serious side effects, including impotence, incontinence, a loss of energy and vitality. Surgery can also have long-term complications, such as damage to the bladder or rectum, and urinary retention. There are, however, significant limitations to these treatments.

Take charge of your health and your life. Contact us today!

More about Darolutamide: New Treatment for Prostate Cancer in 2022

Hormone-sensitive or castration-sensitive prostate cancer means a patient's tumors are still primarily fueled by male sex hormones (androgens). Previously, metastatic hormone-sensitive prostate cancer was treated only with ADT, which blocks the production of androgens by the testicles. 


Darolutamide is a new generation of non-steroidal anti-androgen drugs (NSAIDs) currently being researched to treat prostate cancer. It is an alternative to the current prostate cancer treatment options with a slightly different mechanism of action. 

It is a combination of Darolutamide, androgen deprivation therapy, and Docetaxel. For example, Darolutamide works by blocking androgen receptors (green) in cancer cells from binding to androgens (yellow). It prevents actions that can allow cancer cells to survive and increase.


Here is the image that depicts the above statement with more clarity.

Internationally, the phase 3 ARASENS trial was randomly done on 1305 patients (average age: 67 years) with newly diagnosed metastatic hormone-sensitive prostate cancer. 86% of the patients were newly diagnosed with prostate cancer spreading to the bones or other organs. All the patients received ADT 12 weeks before the trial and six cycles of Docetaxel starting within 6 weeks after the trial. 


  • 651 patients received Docetaxel + standard ADT + Darolutamide 600 mg twice daily.
  • vs. 654 patients received a matched placebo+ Docetaxel + standard ADT.


This trial was published in the New England Journal of Medicine (NEJM) and presented at the February 17th, 2022, American Society of Clinical Oncology (ASCO) Genitourinary Cancers Symposium, held in San Francisco, Calif.


Key points of this latest prostate cancer treatment 


This study's results showed that: 

  • Patients treated with Darolutamide are 32% less likely to die during the follow-up period than patients treated with Docetaxel and ADT alone.
  • About 62.7% of patients who took darolutamide were still alive after 4 years against the approximately 50.4% of patients who received a placebo.
  • During the follow-up, most of the patients in the placebo group (75%) received other commonly used treatments: including abiraterone and enzalutamide. However, compared to that, the group that received darolutamide even lived longer.
  • These patients also had improved time to castration resistance (when despite hormone therapy, the PSA increases and the disease worsens), 
  • Decrease the time to pain progression, and 
  • Symptomatic skeletal-related events (i.e., bone fractures, needing radiation to the bones)), and time to subsequent cancer therapy. Significantly, these improved outcomes of triplet therapy intensification were associated with only a modest increase in adverse events.
  • It does not cause sexual dysfunction, male breast growth (gynecomastia), or a drop in bone density. 
  • It can potentially become a go-to prostate cancer treatment option in the near future.

 It is important to consult a doctor in the best hospital for better treatment.

During a meeting, the study's lead investigator, Matthew R. Smith (M.D., Ph.D., of Massachusetts General Hospital Cancer Center), stated that according to the findings of ARASENS, Darolutamide combined with ADT and Docetaxel should be the new standard of care for treating patients with metastatic hormone-sensitive prostate cancer.

Want to inquire about personalized treatment expenses? Don't hesitate. Talk to us today. 

Side effects of the latest prostate cancer treatment

Darolutamide functions similarly to other androgen receptor inhibitors by preventing androgens from binding to receptors on cancer cells. However,

  • Darolutamide does not breach the blood-brain barrier, in contrast to other androgen receptor inhibitors. 
  • That's the reason that studies have identified fewer central nervous system side effects (such as seizures) with Darolutamide than with other similar medications.
  • The frequency of severe side effects—i.e., bone fractures, needing radiation to the bones, and cardiac issues—was similar in the two groups. Roughly two-thirds of the patients in both groups experienced severe side effects, most of which occurred when Darolutamide (or placebo) was given at the same time as Docetaxel.

Dr. Karzai mentioned that more research is required on how the order in which the drugs are given impacts their effectiveness and the frequency of side effects. 

As per Dr. Smith, that forthcoming studies could look at whether darolutamide and ADT alone could improve survival as well as darolutamide, ADT, and Docetaxel. He said that removing Docetaxel from the combination could reduce some side effects. 

Your well-being is our priority - call us to book your appointment today


Frequently Asked Questions

What is the most common prostate cancer treatment?

What are the five indicators and symptoms of prostate cancer?

What factors should be considered when selecting the best prostate cancer treatment option?

What are the signs and symptoms of prostate cancer?

How long does it take to recover from prostate cancer treatment?

What role do genetic tests play in determining the most effective treatment for prostate cancer?

How do new treatments affect quality of life for prostate cancer patients?

How do new treatments compare in terms of effectiveness and side effects to more established treatments for prostate cancer?

Relevant Blogs

Blog Banner Illustration

Dr. Sandeep Nayak - Best Oncologist in Bangalore

Dr. Sandeep Nayak - Best oncologist in Bangalore. Experience of 19 years. Consults at Fortis, MACS & Ramakrishna. To book an appointment, call @ +91-98678 76979

Blog Banner Image

Eye Cancer Treatment in India ( Know the Best Hospitals, Doctors, Cost And More)

We all agree that eyes are not only one of the most important vital organs but are also important in the appearance of an individual as having beautiful eyes helps with our confidence. Maintaining the health of our eyes is hence very essential, but it has been more and more difficult due to pollution and malnutrition. As a result, the number of Eye cancer cases has been growing over the years, and I would like to provide you with all the information regarding eye cancer. Read on to find more about Eye Cancer Treatment In India.

Blog Banner Image

PET Scan in Mumbai

You’ll find all the available details for the PET scan in Mumbai on this page.

Blog Banner Image

Cancer Treatment in India - Compare Costs, Hospitals & Doctors in 2023

Discover India's world-class cancer treatment options. Get the best care from world-class doctors and hospitals, using the latest technologies and treatments.

Blog Banner Illustration

Organ Specific Cancer Treatment in India

Cancer can occur in all the organs. The treatment plan will differ for different organs based on their site and the intensity of treatment they require. We have further provided the organ specific treatment options for some of the most common types of cancer affecting people all over the world.

Blog Banner Image

15 Best Medical Tourism Companies in India

This article is written with the sole aim to provide you with the information about the best medical tourism companies in India. Medical Tourism has seen a substantial change in the past few years. We want to resolve the main problem faced by the people, "Which medical tourism company should I choose?"

Blog Banner Image

10 Best Hospitals in Istanbul - Updated 2023

Looking for the best hospital in Istanbul? Here is a compact list for you of the 10 Best Hospitals in Istanbul.

Blog Banner Image

List of 15 Best Places of Hair Donation for Cancer Patients in India

Do you wish to donate your hair to people experiencing permanent hair loss due to cancer? But don't know the process? Here is everything you need to know.

Question and Answers

can cervical cancer cause b12 deficiency?

Female | 44

No, cervical cancer does not directly cause B12 deficiency. However, some cancer treatments, such as chemotherapy, may affect the absorption of vitamin B12 in the body, leading to a deficiency. It is important to monitor B12 levels in cancer patients undergoing treatment and supplement as necessary to prevent deficiency.

Answered on 1st Dec'23

Dr. Himali Bhogle

Dr. Himali Bhogle

Answered on 30th Nov'23

Dr. Ganesh Nagarajan

Dr. Ganesh Nagarajan

can lymphoma cause erectile dysfunction?

Male | 41

Lymphoma can cause erectile dysfunction in some cases. This may occur due to the cancer itself, or as a side effect of chemotherapy or radiation therapy. It is important to discuss any sexual dysfunction with your doctor to determine the underlying cause and potential treatment options.

Answered on 30th Nov'23

Dr. Neeta Verma

Dr. Neeta Verma

What is to be done after immunotherapy and elevated liver enzyme levels when seen?

Male | 44

If yellowing of eyes, dark urine, pale stool seen, get your SGPT and SGOT tests done

Answered on 23th Nov'23

Dr. Ganesh Nagarajan

Dr. Ganesh Nagarajan

Cost Of Related Treatments In Country